HomeAnalyzeCompareBlog
← Blog

AMD vs NVIDIA: Which Is the Better Investment in 2026?

StocksAnalyzer·May 8, 2026·9 min read

Disclaimer: This article is for educational purposes only. It does not constitute financial advice or a recommendation to buy or sell. Investing in stocks involves risk of capital loss. Updated: May 8, 2026.

AMD and NVIDIA compete in the same market — chips for artificial intelligence, data centers and high-performance computing — but the data from their diagnostics tell very different stories. One company has perfect fundamentals and trades cheaper. The other has weaker fundamentals and trades more expensively. The outcome of this comparison is clearer than many investors would expect.

Quick Comparison: NVDA vs AMD

MetricNVIDIA (NVDA)AMD
Health Score100 / 10075 / 100
AI SignalPositive OutlookCaution Recommended
ROE101.5%7.1%
Net Margin55.6%12.5%
Gross Margin71.1%52.5%
Revenue Growth88.3%23.6%
Current P/E38.6x138.7x
Forward P/E17.0x32.4x
Market Cap$4.59 trillion$587.8B
Price vs analyst targetBelowAbove (-15.6%)

Financial Health: 100 vs 75

The Health Score difference is not a nuance — it is a structural gap. NVIDIA scores 100/100 with world-class margins: 55.6% net, 71.1% gross, ROE of 101.5% and revenue growth of 88.3%. AMD scores 75/100 with more moderate metrics: 12.5% net margin, 52.5% gross margin and a 7.1% ROE that the diagnostic identifies as the main fundamental weakness.

ROE is the most revealing indicator of the difference between the two companies. NVIDIA generates more than one dollar of profit for every dollar of capital deployed. AMD generates seven cents. The partial explanation is the $49 billion Xilinx acquisition in 2022, which diluted AMD's book equity without the derived earnings having yet reached that level. It is a temporary effect — but one that is still weighing on AMD in 2026.

Valuation: The Surprise of the Analysis

Contrary to what many investors assume, NVIDIA trades cheaper than AMD in P/E and forward P/E terms. NVDA's current P/E is 38.6x versus AMD's 138.7x. The forward P/E is 17.0x (NVDA) versus 32.4x (AMD). In other words: to buy future growth, NVIDIA is the cheaper option of the two. This is because the market expects NVIDIA's earnings to nearly double in 12 months, while AMD needs an even larger earnings expansion to justify its current multiple.

The most striking data point in the comparison: AMD trades at $360.54 when the analyst median price target is $304.24. The stock is already 15.6% above what analysts consider fair value. NVIDIA, by contrast, was trading near its support range with upside according to consensus.

Competitive Position in AI: The Difference That Explains Everything

NVIDIA holds over 80% of the GPU market for AI model training. Its H100 and B200 chips are the de facto standard in the data centers of OpenAI, Google, Meta, and Amazon. AMD competes with its Instinct MI300 family, which is gaining share in inference — processing of already-trained models — and with customers looking to diversify away from NVIDIA. The market share gap explains the margin gap: when you dominate the market, you set the prices.

That does not mean AMD has no value. EPYC in server processors is gaining share against Intel. And in AI, being the second provider in a multi-trillion dollar market is still a massive business. But in terms of business quality as measured by the diagnostic, the difference is clear.

Technical Signals: Both Have Golden Cross, But in Very Different Situations

Both have a confirmed Golden Cross — a medium-term bullish trend signal. But AMD's RSI at 83.5 indicates extreme overbought conditions, with the price near 52-week highs and immediate resistance at $362.79. NVIDIA's RSI at 68.3 was more moderate with technical room before an overbought signal. AMD's volatility (60.3%) is nearly double NVIDIA's (34.8%), amplifying risk in both directions.

AI Signal: Positive vs Caution

The diagnostic assigns a "Positive Outlook" signal to NVIDIA and "Caution Recommended" to AMD. The difference reflects exactly what the data shows: NVIDIA has fundamentals that justify an elevated valuation; AMD has weaker fundamentals and a valuation that already anticipates very ambitious growth.

Who Is Each Stock For?

NVIDIA is the option for an investor who wants exposure to the AI market with the best available fundamentals. It is more expensive in absolute price but cheaper in growth multiples. The risks are a deceleration in AI capex spending or the arrival of competitors with alternative chips (AMD, Intel, in-house chips from Google/Meta).

AMD is the speculative option for those who believe the company can capture more AI market share and that earnings will eventually force analyst models to upgrade significantly. It is a higher-risk, higher-asymmetric-potential bet if the thesis plays out. The problem is that today's data does not support paying 138x earnings for that bet.

Frequently Asked Questions: AMD vs NVIDIA

Why does NVIDIA have a lower P/E than AMD if it is a larger company?

Because NVIDIA generates far higher earnings relative to its market cap. P/E measures price divided by earnings per share — the more profit the company generates per dollar of market cap, the lower the P/E. NVIDIA generated 55.6% net margins on revenues that grew 88.3%. AMD generates 12.5% margins on revenues that grew 23.6%. The market pays more per dollar of AMD earnings because it expects that ratio to improve dramatically; with NVIDIA it already sees it proven.

Can AMD catch up to NVIDIA in the AI market?

In the short term, unlikely. NVIDIA has a software ecosystem (CUDA) that has been building for over 15 years and which AI developers know and prefer. AMD needs teams to adopt ROCm (its alternative) — a slow process. In the inference segment (not training), AMD is gaining share faster because the software barrier is lower. Over a 3-5 year horizon, AMD can play a significant role, but it is unlikely to reach NVIDIA's position in the training market.

Which has the better long-term risk profile?

NVIDIA. Health Score 100 vs 75, superior margins, much higher ROE and a positive AI signal versus Caution Recommended. In terms of risk/reward ratio based on the diagnostic data, NVIDIA is the more fundamentally sound option. AMD may offer greater percentage upside if it executes its thesis, but also greater correction risk if it disappoints.

Where can I see the individual analysis of each company?

You can read the full NVIDIA analysis at stocksanalyzer.app/blog/nvidia-stock-analysis-2026 and the AMD analysis at stocksanalyzer.app/blog/amd-stock-analysis-2026. For real-time data on either, use the analyzer at stocksanalyzer.app/analyze by entering the NVDA or AMD ticker.

Reference sources: SEC (U.S. Securities and Exchange Commission) — sec.gov | Damodaran Online, NYU Stern School of Business — pages.stern.nyu.edu/~adamodar | CFA Institute — cfainstitute.org

Written by the StocksAnalyzer team. Content reviewed and updated as of May 8, 2026. This article is for educational purposes only and does not constitute financial advice or investment recommendation.

Related articles

Is AMD Stock a Buy in 2026? AMD Analysis With Pros, Cons and Price Target

Should you buy AMD today? RSI at 83.5 (overbought), price above analyst median target and a "Caution Recommended" signal. The most complete AMD analysis with real data ahead of May 5 earnings.

NVIDIA Stock Analysis 2026: Is NVDA a Buy at Current Prices?

Is NVDA overvalued or a buying opportunity? Health Score 100, RSI 68.3, forward P/E of 17x and confirmed Golden Cross. Full analysis with real data from April 2026.

What is the Health Score and how to interpret it?

The Health Score is a 0-100 rating that summarizes a company's financial health in a single number.